Buscar
Mostrando ítems 1-9 de 9
Current management practices for acromegaly: an international survey
(SPRINGER, 2011)
To determine whether peer-reviewed consensus statements have changed clinical practice, we surveyed acromegaly care in specialist centers across the globe, and determined the degree of adherence to published consensus ...
Brazilian multicenter study on pegvisomant treatment in acromegaly
(Sociedade Brasileira de Endocrinologia e Metabologia, 2019)
Objective Investigate the therapeutic response of acromegaly patients to pegvisomant (PEGV) in a real-life, Brazilian multicenter study. Subjects and methods Characteristics of acromegaly patients treated with PEGV were ...
Pituitary gigantism: a case series from Hospital de San José (Bogotá, Colombia)
(Sociedad Brasileña de Endocrinología y MetabologíaBrasil, 2019-04)
Introduction: Gigantism is a rare pediatric disease characterized by increased production of growth
hormone (GH) before epiphyseal closure, that manifests clinically as tall stature, musculoskeletal
abnormalities, and ...
Tratamento medicamentoso dos tumores hipofisários. Parte I : prolactinomas e adenomas secretores de GH
(Sociedade Brasileira de Endocrinologia e Metabologia, 2000-10)
O recente desenvolvimento de novas drogas, particularmente os análogos da somatotastina (SRIFa), representou um grande progresso na terapia dos tumores hipofisários. Os SRIFa mostram-se bastante eficazes na normalização ...
Growth hormone regulates neuroendocrine responses to weight loss via AgRP neurons
(Nature Publishing Group, 2019-12)
Weight loss triggers important metabolic responses to conserve energy, especially via the fall in leptin levels. Consequently, weight loss becomes increasingly difficult with weight regain commonly occurring in most dieters. ...